Jenna H. Burton

1.7k total citations · 1 hit paper
44 papers, 995 citations indexed

About

Jenna H. Burton is a scholar working on Pulmonary and Respiratory Medicine, Small Animals and Genetics. According to data from OpenAlex, Jenna H. Burton has authored 44 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 18 papers in Small Animals and 10 papers in Genetics. Recurrent topics in Jenna H. Burton's work include Veterinary Oncology Research (33 papers), Infectious Diseases and Mycology (14 papers) and Virus-based gene therapy research (9 papers). Jenna H. Burton is often cited by papers focused on Veterinary Oncology Research (33 papers), Infectious Diseases and Mycology (14 papers) and Virus-based gene therapy research (9 papers). Jenna H. Burton collaborates with scholars based in United States, United Kingdom and Israel. Jenna H. Burton's co-authors include Douglas H. Thamm, Steven Dow, Barbara J. Biller, Laura E. Selmic, Susan E. Lana, Robert B. Rebhun, Stephen J. Withrow, David M. Vail, Amanda Guth and Elizabeth Garrett‐Mayer and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

In The Last Decade

Jenna H. Burton

43 papers receiving 956 citations

Hit Papers

Veterinary Cooperative Oncology Group—Common Terminology ... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG‐CTCAE v2) following investigational therapy in dogs and cats
    2021 177 citations Amy K. LeBlanc, Jenna H. Burton et al. Veterinary and Comparative Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jenna H. Burton United States 17 696 317 290 227 167 44 995
Kristine Burgess United States 20 736 1.1× 269 0.8× 335 1.2× 170 0.7× 169 1.0× 40 1.1k
Marina Martano Italy 24 985 1.4× 395 1.2× 336 1.2× 181 0.8× 233 1.4× 65 1.4k
Brenda Phillips United States 15 538 0.8× 230 0.7× 233 0.8× 89 0.4× 113 0.7× 28 721
Sarah C. Charney United States 17 506 0.7× 169 0.5× 204 0.7× 183 0.8× 219 1.3× 22 824
Michelle Turek United States 18 795 1.1× 214 0.7× 351 1.2× 108 0.5× 118 0.7× 46 1.2k
Erika Krick United States 15 538 0.8× 218 0.7× 322 1.1× 119 0.5× 77 0.5× 28 708
Silvia Sabattini Italy 21 1.1k 1.5× 236 0.7× 634 2.2× 169 0.7× 128 0.8× 85 1.2k
Corey Saba United States 17 627 0.9× 233 0.7× 272 0.9× 72 0.3× 160 1.0× 48 933
Emanuela Morello Italy 25 1.2k 1.7× 462 1.5× 463 1.6× 226 1.0× 275 1.6× 96 1.7k
Kenji Hosoya Japan 15 374 0.5× 157 0.5× 181 0.6× 104 0.5× 119 0.7× 66 755

Countries citing papers authored by Jenna H. Burton

Since Specialization
Citations

This map shows the geographic impact of Jenna H. Burton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenna H. Burton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenna H. Burton more than expected).

Fields of papers citing papers by Jenna H. Burton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenna H. Burton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenna H. Burton. The network helps show where Jenna H. Burton may publish in the future.

Co-authorship network of co-authors of Jenna H. Burton

This figure shows the co-authorship network connecting the top 25 collaborators of Jenna H. Burton. A scholar is included among the top collaborators of Jenna H. Burton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenna H. Burton. Jenna H. Burton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Woolard, Kevin, et al.. (2023). High-Grade, Stage 2 Mast Cell Tumors: Outcome in Dogs With Local and Systemic Therapy. Journal of the American Animal Hospital Association. 59(4). 167–176. 1 indexed citations
3.
Burton, Jenna H., Stephen Albert Johnston, David M. Vail, et al.. (2023). Design of a randomized, placebo-controlled study evaluating efficacy and safety of a cancer preventative vaccine in dogs. Veterinary Immunology and Immunopathology. 267. 110691–110691. 5 indexed citations
4.
Skorupski, Katherine A., Barbara A. Byrne, Carrie A. Palm, & Jenna H. Burton. (2022). Prospective comparison of prostatic aspirate culture and cystocentesis urine culture for detection of bacterial infection in dogs with prostatic neoplasia. Journal of Small Animal Practice. 63(12). 858–862. 1 indexed citations
5.
Culp, William T. N., Eric G. Johnson, Michelle A. Giuffrida, et al.. (2022). Evaluation of the use of a novel bioabsorbable polymer drug-eluting microsphere for transarterial embolization of hepatocellular neoplasia in dogs. PLoS ONE. 17(8). e0269941–e0269941. 2 indexed citations
6.
Johnson, Eric G., Carrie A. Palm, Jenna H. Burton, et al.. (2022). MRI characteristics of canine prostatic neoplasia. Veterinary Radiology & Ultrasound. 64(1). 105–112. 3 indexed citations
7.
Willcox, Jennifer L., Mathieu Spriet, Allison L. Zwingenberger, et al.. (2020). Evaluation of accuracy for18F‐FDG positron emission tomography and computed tomography for detection of lymph node metastasis in canine oral malignant melanoma. Veterinary and Comparative Oncology. 19(3). 463–472. 8 indexed citations
8.
Willcox, Jennifer L., Jenna H. Burton, Yu Ueda, et al.. (2020). Intramuscular Diphenhydramine Does Not Affect Acute Doxorubicin Infusion-Related Arrhythmia Number or Severity in a Prospective Crossover Study in Canine Lymphoma: A Pilot Study. Frontiers in Veterinary Science. 7. 368–368. 2 indexed citations
9.
Withers, Sita S., Daniel York, Eric G. Johnson, et al.. (2018). In vitro and in vivo activity of liposome‐encapsulated curcumin for naturally occurring canine cancers. Veterinary and Comparative Oncology. 16(4). 571–579. 18 indexed citations
10.
Mayhew, Philipp D., Michelle A. Giuffrida, Jeffrey J. Runge, et al.. (2018). Association of surgical approach with complication rate, progression-free survival time, and disease-specific survival time in cats with mammary adenocarcinoma: 107 cases (1991–2014). Journal of the American Veterinary Medical Association. 252(11). 1393–1402. 19 indexed citations
11.
Rebhun, Robert B., et al.. (2018). Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma. BMC Veterinary Research. 14(1). 356–356. 15 indexed citations
12.
Kent, Michael S., Jenna H. Burton, Gillian Dank, Danika L. Bannasch, & Robert B. Rebhun. (2018). Association of cancer-related mortality, age and gonadectomy in golden retriever dogs at a veterinary academic center (1989-2016). PLoS ONE. 13(2). e0192578–e0192578. 39 indexed citations
13.
Vernau, William, et al.. (2017). Patient characteristics, prognostic factors and outcome of dogs with high‐grade primary mediastinal lymphoma. Veterinary and Comparative Oncology. 16(1). E45–E51. 12 indexed citations
14.
Schmidt, Amand F., M. Nielen, Stephen J. Withrow, et al.. (2016). Chemotherapy effectiveness and mortality prediction in surgically treated osteosarcoma dogs: A validation study. Preventive Veterinary Medicine. 125. 126–134. 3 indexed citations
15.
Burton, Jenna H., Scott D. Stanley, Heather K. Knych, et al.. (2015). Frequency and Severity of Neutropenia Associated with Food and Drug Administration Approved and Compounded Formulations of Lomustine in Dogs with Cancer. Journal of Veterinary Internal Medicine. 30(1). 242–246. 20 indexed citations
16.
Eiseman, Julie L., Julianne L. Holleran, David L. McCormick, et al.. (2015). Abstract 4517: Plasma and tumor pharmacokinetics of IV LMP744, a novel indenoisoquinoline topoisomerase I inhibitor, in a canine phase I study. Cancer Research. 75(15_Supplement). 4517–4517. 1 indexed citations
17.
Burton, Jenna H., et al.. (2014). Phase II Evaluation of VDC-1101 in Canine Cutaneous T-Cell Lymphoma. Journal of Veterinary Internal Medicine. 28(5). 1569–1574. 24 indexed citations
18.
Avery, Paul R., Jenna H. Burton, Davis Seelig, et al.. (2014). Flow Cytometric Characterization and Clinical Outcome of CD4+ T-Cell Lymphoma in Dogs: 67 Cases. Journal of Veterinary Internal Medicine. 28(2). 538–546. 50 indexed citations
19.
Selmic, Laura E., Jenna H. Burton, Douglas H. Thamm, Stephen J. Withrow, & Susan E. Lana. (2014). Comparison of Carboplatin and Doxorubicin-Based Chemotherapy Protocols in 470 Dogs after Amputation for Treatment of Appendicular Osteosarcoma. Journal of Veterinary Internal Medicine. 28(2). 554–563. 116 indexed citations
20.
Biller, Barbara J., Amanda Guth, Jenna H. Burton, & Steven Dow. (2010). Decreased Ratio of CD8+ T Cells to Regulatory T Cells Associated with Decreased Survival in Dogs with Osteosarcoma. Journal of Veterinary Internal Medicine. 24(5). 1118–1123. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristine Burgess Breakdown of academic impact, for papers by Marina Martano Breakdown of academic impact, for papers by Brenda Phillips Breakdown of academic impact, for papers by Sarah C. Charney Breakdown of academic impact, for papers by Michelle Turek Breakdown of academic impact, for papers by Erika Krick Breakdown of academic impact, for papers by Silvia Sabattini Breakdown of academic impact, for papers by Corey Saba Breakdown of academic impact, for papers by Emanuela Morello Breakdown of academic impact, for papers by Kenji Hosoya
Rankless by CCL
2026